• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Kinetics of the reaction of renin with nine synthetic peptide substrates.肾素与九种合成肽底物反应的动力学
J Exp Med. 1968 Jul 1;128(1):13-34. doi: 10.1084/jem.128.1.13.
2
Renin cleavage of a human kidney renin substrate analogous to human angiotensinogen, H-Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-Val-Ile-His-Ser-OH, that is human renin specific and is resistant to cathepsin D.人肾素对一种类似于人血管紧张素原(H-天冬氨酸-精氨酸-缬氨酸-酪氨酸-异亮氨酸-组氨酸-脯氨酸-苯丙氨酸-组氨酸-亮氨酸-缬氨酸-异亮氨酸-组氨酸-丝氨酸-OH)的人肾素底物进行裂解,该底物具有人肾素特异性且对组织蛋白酶D有抗性。
Anal Biochem. 1984 Aug 1;140(2):459-67. doi: 10.1016/0003-2697(84)90194-5.
3
On the specificity of human renin. Studies with peptide inhibitors.关于人肾素的特异性。肽抑制剂研究。
Biochim Biophys Acta. 1976 Dec 8;452(2):533-7. doi: 10.1016/0005-2744(76)90205-9.
4
Design, structure-activity, and molecular modeling studies of potent renin inhibitory peptides having N-terminal Nin-For-Trp (Ftr): angiotensinogen congeners modified by P1-P1' Phe-Phe, Sta, Leu psi[CH(OH)CH2]Val or leu psi[CH2NH]Val substitutions.具有N端Nin-For-Trp(Ftr)的强效肾素抑制肽的设计、构效关系及分子模拟研究:经P1-P1'苯丙氨酸-苯丙氨酸、斯塔汀、亮氨酸ψ[CH(OH)CH2]缬氨酸或亮氨酸ψ[CH2NH]缬氨酸取代修饰的血管紧张素原类似物
J Med Chem. 1988 Jan;31(1):18-30. doi: 10.1021/jm00396a006.
5
The preparation, purification, and amino acid sequence of a polypeptide renin substrate.一种多肽肾素底物的制备、纯化及氨基酸序列
J Exp Med. 1957 Sep 1;106(3):439-53. doi: 10.1084/jem.106.3.439.
6
Conformations of synthetic tetradecapeptide renin substrate and of angiotensin I in aqueous solution.合成十四肽肾素底物和血管紧张素I在水溶液中的构象。
Biochemistry. 1977 Jun 14;16(12):2606-11. doi: 10.1021/bi00631a005.
7
Expression and characterization of chimeric rDNA proteins engineered for purification and enzymatic cleavage.为纯化和酶切而设计的嵌合核糖体DNA蛋白的表达与表征
Protein Expr Purif. 1991 Apr-Jun;2(2-3):205-13. doi: 10.1016/1046-5928(91)90073-r.
8
Highly sensitive intramolecularly quenched fluorogenic substrates for renin based on the combination of L-2-amino-3-(7-methoxy-4-coumaryl)propionic acid with 2,4-dinitrophenyl groups at various positions.基于L-2-氨基-3-(7-甲氧基-4-香豆基)丙酸与不同位置的2,4-二硝基苯基基团组合的用于肾素的高灵敏度分子内淬灭荧光底物。
Biochem J. 2004 Sep 15;382(Pt 3):1031-8. doi: 10.1042/BJ20040729.
9
Substrate specificity of cucumisin on synthetic peptides.黄瓜蛋白酶对合成肽的底物特异性。
Biosci Biotechnol Biochem. 2000 Oct;64(10):2104-8. doi: 10.1271/bbb.64.2104.
10
Intramolecularly quenched fluorogenic peptide substrates for human renin.用于人肾素的分子内淬灭荧光肽底物。
Anal Biochem. 1992 May 15;203(1):39-46. doi: 10.1016/0003-2697(92)90040-e.

引用本文的文献

1
Angiotensin 1-7 Receptor and Angiotensin II Receptor 2 Blockades Prevent the Increased Serum and Kidney Nitric Oxide Levels in Response to Angiotensin II Administration: Gender-Related Difference.血管紧张素1-7受体和血管紧张素II受体2阻断可预防因给予血管紧张素II而导致的血清和肾脏一氧化氮水平升高:性别相关差异。
Int J Prev Med. 2013 Mar;4(3):311-5.
2
Renin inhibition.肾素抑制
Cardiovasc Drugs Ther. 1995 Oct;9(5):645-55. doi: 10.1007/BF00878547.
3
The clinical potential of renin inhibitors and angiotensin antagonists.肾素抑制剂和血管紧张素拮抗剂的临床潜力。
Drugs. 1994 Apr;47(4):586-98. doi: 10.2165/00003495-199447040-00003.
4
Inhibition of renin by conformationally restricted analogues of angiotensinogen.血管紧张素原构象受限类似物对肾素的抑制作用。
Biochem J. 1982 Jul 1;205(1):43-7. doi: 10.1042/bj2050043.
5
Haemodynamic responses to specific renin-angiotensin inhibitors in hypertension and congestive heart failure. A review.高血压和充血性心力衰竭患者对特定肾素-血管紧张素抑制剂的血流动力学反应。综述。
Drugs. 1984 Aug;28(2):144-69. doi: 10.2165/00003495-198428020-00004.
6
A radiochemical renin assay.放射化学肾素测定法。
Biochem J. 1971 Jan;121(2):241-4. doi: 10.1042/bj1210241.
7
[Renin-angiotensin-aldosterone system from the pathophysiological viewpoint].从病理生理学角度看肾素-血管紧张素-醛固酮系统
Klin Wochenschr. 1969 Dec 1;47(23):1247-55. doi: 10.1007/BF01487550.
8
Renin inhibitors.肾素抑制剂
Pharm Res. 1987 Oct;4(5):364-74. doi: 10.1023/a:1016422009662.

本文引用的文献

1
THE SYNTHESIS OF 9-CITRULLINE, 9-HISTIDINE, AND 9-DESARGININE BRADYKININ.9-瓜氨酸缓激肽、9-组氨酸缓激肽和9-去精氨酸缓激肽的合成
J Med Chem. 1964 Jan;7:50-3. doi: 10.1021/jm00331a011.
2
The purification and partial characterization of several forms of hog renin substrate.几种形式的猪肾素底物的纯化及部分特性分析
J Exp Med. 1963 Jul;118(1):73-98. doi: 10.1084/jem.118.1.73.
3
The synthesis of a tetradecapeptide renin substrate.一种十四肽肾素底物的合成。
J Exp Med. 1958 Sep 1;108(3):283-97. doi: 10.1084/jem.108.3.283.
4
The preparation, purification, and amino acid sequence of a polypeptide renin substrate.一种多肽肾素底物的制备、纯化及氨基酸序列
J Exp Med. 1957 Sep 1;106(3):439-53. doi: 10.1084/jem.106.3.439.
5
Amino-acid sequence in a hypertensin.高血压素中的氨基酸序列。
Nature. 1956 Mar 17;177(4507):527-8. doi: 10.1038/177527a0.
6
A simple method for the extraction and partial purification of renin.一种提取和部分纯化肾素的简单方法。
Arch Biochem Biophys. 1954 Feb;48(2):256-60. doi: 10.1016/0003-9861(54)90339-2.
7
Synthesis and biological activities of a tetradecapeptide renin substrate.一种十四肽肾素底物的合成与生物活性
Am J Physiol. 1966 Mar;210(3):591-4. doi: 10.1152/ajplegacy.1966.210.3.591.
8
Studies on the preparation and properties of renin.肾素的制备及其性质研究。
Circ Res. 1967 Jul;21(1):Suppl 2:91+.

肾素与九种合成肽底物反应的动力学

Kinetics of the reaction of renin with nine synthetic peptide substrates.

作者信息

Skeggs L T, Lentz K E, Kahn J R, Hochstrasser H

出版信息

J Exp Med. 1968 Jul 1;128(1):13-34. doi: 10.1084/jem.128.1.13.

DOI:10.1084/jem.128.1.13
PMID:5662012
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2138508/
Abstract

A number of peptides have been synthesized which represent portions of the tetradecapeptide renin substrate molecule, and which contain the hydrolyzable leu-leu bond. An automatic chemical method for determination of the velocity of the reaction of renin with these compounds was developed. Application of the method at several levels of substrate concentration permitted construction of Lineweaver-Burk plots, and calculation of Michaelis constants (K(m)) and maximal velocities (V(max)). The results show that the maximum affinity of the enzyme (lowest K(m)) for substrate is achieved only with the full tetradecapeptide molecule (asp(1)-arg(2)-val(3)-tyr(4)-ileu(5)-his(6)-pro(7)-phe(8)-his(9)-leu(10)-leu(11)-val(12)-tyr(13)-ser(14)). Removal of asp(1) and arg(2) from the N-terminal increases the K(m) eight-fold. Further, moderate increase in K(m) occurs when the next amino acids, val(3), tyr(4) and ileu(5), are removed. The further removal of his(6) results in a marked reduction in the V(max). Removal of ser(14) from the C-terminal of the nonapeptide his(6)-pro(7)-phe(8)-his(9)-leu(10)-leu(11)-val(12)-tyr(13)-ser(14) does not greatly affect the K(m) nor the V(max). Further removal of tyr(13) from this compound results in complete loss of substrate activity. It is suggested that the compounds his(6)-pro(7)-phe(8)-his(9)-leu(10)-leu(11)-val(12)-tyr(13)-ser(14) or his(6)-pro(7)-phe(8)-his(9)-leu(10)-leu(11)-val(12)-tyr(13) might be used as substrates for the chemical assay and standardization of renin.

摘要

已合成了多种肽,它们代表十四肽肾素底物分子的部分片段,并且含有可水解的亮氨酸 - 亮氨酸键。开发了一种自动化学方法来测定肾素与这些化合物反应的速度。在几个底物浓度水平上应用该方法可以构建林-贝氏图,并计算米氏常数(K(m))和最大速度(V(max))。结果表明,只有完整的十四肽分子(天冬氨酸(1)-精氨酸(2)-缬氨酸(3)-酪氨酸(4)-异亮氨酸(5)-组氨酸(6)-脯氨酸(7)-苯丙氨酸(8)-组氨酸(9)-亮氨酸(10)-亮氨酸(11)-缬氨酸(12)-酪氨酸(13)-丝氨酸(14))才能使酶对底物具有最大亲和力(最低的K(m))。从N端去除天冬氨酸(1)和精氨酸(2)会使K(m)增加8倍。此外,当去除接下来的氨基酸缬氨酸(3)、酪氨酸(4)和异亮氨酸(5)时,K(m)会适度增加。进一步去除组氨酸(6)会导致V(max)显著降低。从九肽组氨酸(6)-脯氨酸(7)-苯丙氨酸(8)-组氨酸(9)-亮氨酸(10)-亮氨酸(11)-缬氨酸(12)-酪氨酸(13)-丝氨酸(14)的C端去除丝氨酸(14)对K(m)和V(max)影响不大。从该化合物中进一步去除酪氨酸(13)会导致底物活性完全丧失。有人提出,化合物组氨酸(6)-脯氨酸(7)-苯丙氨酸(8)-组氨酸(9)-亮氨酸(10)-亮氨酸(11)-缬氨酸(12)-酪氨酸(13)-丝氨酸(14)或组氨酸(6)-脯氨酸(7)-苯丙氨酸(8)-组氨酸(9)-亮氨酸(10)-亮氨酸(11)-缬氨酸(12)-酪氨酸(13)可作为肾素化学测定和标准化的底物。